Akero Therapeutics, Inc. sold the stake/assets to Novo Nordisk A/S as part of a acquisition on not available.
Deal value was 5200000000 (source: Extracted) Sector: Healthcare; Location: USA.
On the seller side, counsel was not available; lawyers included Graham Robinson, Laura Knoll, Chade Severin, Benjamin Jiang, Greg Schuster, Kevin Perron, Adam Hustad, Zohra Yaqhubi, Eric Solomine, Matthew Kelly, Maria Raptis, Thomas Sebastian Wilson, Margarita Karkantzou, Joel Gory, Rachel Malhiet, Dean Shulman, Benjamin Schreiner, Grant Perkins, Mari Stonebraker, Kaitlyn Hodgman, Jason Serlenga, Jeff Feldmann, Dennis Williams, Will Richmond, Brian King, Stefan Atkinson, Alyssa Scruggs, Ava Roche, Zachary Brez, John Kabealo, Bryan Applefeld, Tim Nelson, Mei Wang, Ann Becchina, Justin Coddington, Ethan Kirner, Shellie Freedman, Amber Harezlak, Molly Mahowald.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises Akero Therapeutics on $5.2 billion sale to Novo Nordisk | The Sponsor - The Sponsor
